Gainers & Losers

YOU ARE ON :

HOME /
IPO /
IPO ISSUES /
IPO-SYNOPSIS

Sai Parenteral's Ltd

Registered Office: No.39 5th Flr Lavanya Arcade-,Jayabheri Enclave Gachibowli, Rangareddy - 500032, Telangana, India.
Phone : +91 79979 91301 Fax:
Email : cs@saiparenterals.com
Website : https://www.saiparenterals.com

Initial public offer of 10,428,288 equity shares of face value of Rs. 5 each ("Equity Shares") of Sai Parenteral's Limited ("Company" or "Issuer") for cash at a price of Rs. 392 per equity share (Including a Share Premium of Rs. 387 Per Equity Share) ("Offer Price") aggregating to Rs. 408.79 Crore comprising a fresh issue of 7,270,408 equity shares of face value of Rs. 5 each aggregating to Rs. 285 Crore by the company ("Fresh Issue") and an offer for sale of 3,157,880 equity shares of face value of Rs. 5 each aggregating to Rs. 123.79 Crore ("Offered Shares") by investor selling shareholders (such sale, the "Offer For Sale", and together with the fresh issue, the"Offer"). The offer shall constitute 23.60% of the post-offer paid up equity share capital of the company. Price Band: Rs. 392 per equity share of face value of Rs. 5 each. The floor price is 78.40 times the face value of the equity shares. Bids can be made for a minimum of 38 equity shares of face value of Rs. 5 each and in multiples of 38 equity shares of face value of Rs. 5 each thereafter.

Issue		Money Payable On
Opens on	Closes On	Application	Allotment
24-Mar-26	27-Mar-26	392.00-0.00	0.00-0.00

Minimum Application for shares in Nos : 38 Further Multiples of : 38

	Rs(Cr.)	Lead Managers to the Issue
Project Cost	256.50	Arihant Capital Markets Limited
Project Financed through Current Offer	408.79
Post Issue Equity Share Capital	22.09
Issue Price	392.00

Project

Capacity expansion and upgradation of manufacturing facilities

Establishment of a new R&D Centre

Repayment / prepayment of certain outstanding borrowings

Working capital requirements

Investment in wholly owned subsidiary, Sai Parenterals Pte Limited (Singapore), in relation to the proposed acquisition of Noumed Pharmaceuticals Pty Limited (Australia)

General corporate purposes

Promoted By

Anil Kumar Karusala

Vijitha Gorrepati

Karusala Aruna

Listing At

BSE

NSE

Registrar to the Issue

Bigshare Services Pvt Ltd

Attention Investor:

1) "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary." 2) For Stock Broking Transaction "Prevent unauthorised transactions in your account Update your mobile numbers / email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile / email at the end of the day .... Issued in the interest of Investors." 3) For Depository Transaction "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....Issued in the interest of investors." 4) No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.

Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)